CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 80 filers reported holding CATALYST BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,500,000 | -49.4% | 365,000 | -46.7% | 0.53% | -55.4% |
| Q2 2021 | $2,966,000 | -37.4% | 685,000 | -27.1% | 1.18% | -30.6% |
| Q1 2021 | $4,735,000 | -44.7% | 939,500 | -30.8% | 1.71% | -26.8% |
| Q4 2020 | $8,566,000 | +33.0% | 1,357,500 | -9.4% | 2.33% | +33.3% |
| Q3 2020 | $6,441,000 | -26.7% | 1,497,900 | 0.0% | 1.75% | -31.2% |
| Q2 2020 | $8,793,000 | +45.3% | 1,497,900 | +8.2% | 2.54% | -13.4% |
| Q1 2020 | $6,051,000 | -37.5% | 1,384,600 | +66.8% | 2.93% | +70.1% |
| Q2 2018 | $9,686,000 | -67.5% | 830,000 | -28.1% | 1.72% | -64.6% |
| Q1 2018 | $29,792,000 | +385.4% | 1,154,722 | +156.6% | 4.87% | +319.8% |
| Q4 2017 | $6,138,000 | – | 450,000 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |